Comparison of the potency of phenylephrine and norepinephrine bolus doses used to treat post-spinal hypotension during elective caesarean section
International Journal of Obstetric Anesthesia |
Dec 19, 2018
Antimicrobial exposure and the risk of delirium in critically ill patients
Critical Care |
Dec 18, 2018
3 reasons to join M3 India Market Research Panel
- Contribute to improvements in Healthcare by sharing your insights
- Earn rewards in your free time
- Secure: We never share your personal information without your permission
Over 4 million Doctors across 9 countries
trust M3 Group for their daily practice.
M3 India is a Joint Venture between M3 Inc. Japan and Health Care at Home India Pvt. Ltd.
By leveraging internet based technologies, this initiative will expand access to information and enhance communication in the Indian healthcare sector.